Cargando…

Cutaneous metastasis emerging during chemotherapy and progressing during immunotherapy for urothelial carcinoma

INTRODUCTION: Cutaneous metastasis of urothelial carcinoma is uncommon. We experienced a case of cutaneous metastasis that emerged during chemotherapy and progressed rapidly during immunotherapy for bladder tumor with lymph node metastasis. CASE PRESENTATION: A 77‐year‐old female patient received ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsuka, Isamu, Ueno, Takashi, Terada, Naoki, Mukai, Shoichiro, Fukushima, Tsuyoshi, Kiwaki, Takumi, Nagano, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560435/ https://www.ncbi.nlm.nih.gov/pubmed/34755057 http://dx.doi.org/10.1002/iju5.12350

Ejemplares similares

Malignant pheochromocytoma with liver invasion treated successfully by combined retroperitoneal laparoscopic control of arterial in-flow followed by open hepatectomy: A case report
por: Otsuka, Isamu, et al.
Publicado: (2021)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report
por: Iwata, Shohei, et al.
Publicado: (2021)

Cutaneous metastasis of bladder urothelial carcinoma; A rare conditions
por: Öztürk, Hakan, et al.
Publicado: (2021)

Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium
por: Kawaguchi, Makiko, et al.
Publicado: (2023)

Cutaneous metastasis of urothelial carcinoma resulting in vascular occlusion and livedo racemosa
por: Savell, Anita S., et al.
Publicado: (2020)

Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report
por: Kawasoe, Chihiro, et al.
Publicado: (2023)

Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in Apc (Min/+) mice
por: Kawaguchi, Makiko, et al.
Publicado: (2020)

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells
por: Izumi, Aya, et al.
Publicado: (2022)

Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine
por: Kiwaki, Takumi, et al.
Publicado: (2022)

Multiple cutaneous metastasis of synchronous urothelial carcinoma of the bladder and the renal pelvis: a case report
por: Ghalleb, M., et al.
Publicado: (2019)

Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms
por: Otsuka, Isao
Publicado: (2019)

Cutaneous metastasis as a complication of hepatic intra-arterial chemotherapy.
por: O'Hagan, S., et al.
Publicado: (1997)

A pilot study on a potential relationship between leg bone length and sprint performance in sprinters; are there any event-related differences in 100-m and 400-m sprints?
por: Tomita, Daichi, et al.
Publicado: (2020)

No Correlation Between Plantar Flexor Muscle Volume and Sprint Performance in Sprinters
por: Miyake, Yuto, et al.
Publicado: (2021)

Generalized herpes zoster and cutaneous metastasis during chemotherapy for non‐small cell lung cancer: A case report
por: Yasokawa, Naoya, et al.
Publicado: (2020)

En bloc removal of a large leiomyosarcoma arising from the inferior vena cava using retroperitoneal laparoscopic dissection of posterior vessels followed by cavectomy in a thoracoabdominal approach
por: Kida, Kazutaka, et al.
Publicado: (2019)

A case of von Hippel–Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy
por: Akioka, Takahiro, et al.
Publicado: (2021)

Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review
por: Izzo, Paolo, et al.
Publicado: (2023)

Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation
por: Yamasaki, Koji, et al.
Publicado: (2018)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
por: Kitamura, Hiroshi, et al.
Publicado: (2011)

Immunotherapy in urothelial carcinoma: fade or future standard?
por: Breyer, Johannes, et al.
Publicado: (2016)

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
por: Miura, Yuki, et al.
Publicado: (2021)

Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias
por: Otsuka, Hikari, et al.
Publicado: (2022)

Update on Chemotherapy in the Treatment of Urothelial Carcinoma
por: Costantini, Carrie, et al.
Publicado: (2011)

Exceptional response to immunotherapy in association with radiotherapy in patient with breast metastasis from urothelial carcinoma: A case report
por: Bonfante, Giulia, et al.
Publicado: (2020)

Understanding the biology of urothelial cancer metastasis
por: Kobayashi, Takashi
Publicado: (2016)

Choroidal and Cutaneous Metastasis from Urothelial Carcinoma of the Bladder after Radical Cystectomy: A Case Report and Literature Review
por: Mitsui, Yozo, et al.
Publicado: (2014)

Erratum: Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review
Publicado: (2023)

Comparison of the relative muscle volume of triceps surae among sprinters, runners, and untrained participants
por: Fukutani, Atsuki, et al.
Publicado: (2020)

Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers
por: Mukai, Shoichiro, et al.
Publicado: (2020)

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021)

Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma
por: Kohei, Naoki, et al.
Publicado: (2018)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Role of immunotherapy in localized muscle invasive urothelial cancer
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
por: Zhang, Yueming, et al.
Publicado: (2021)

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma
por: Benjamin, David J, et al.
Publicado: (2022)

Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab
por: Chiang, Ryan S, et al.
Publicado: (2022)

Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
por: Anraku, Tsutomu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rfkq8sqesiu5caettqbbip2fk8